Our Services
Medical Information
Helpful Resources
Published on: 3/12/2026
There are several factors to consider; many people do not fully improve on antidepressants because depression often involves brain circuit dysfunction, genetics, inflammation, stress systems, and sleep issues, leading to treatment-resistant depression.
TMS is an FDA-cleared, noninvasive option that directly targets these underactive mood circuits and can help when meds fail, and the steps for candidacy, the typical 4 to 6 week course, safety, insurance, and urgent signs to act on are explained below.
If you've been taking antidepressants but still don't feel like yourself, you're not alone. Many people assume medication will "fix" depression or anxiety quickly. But for a significant number of individuals, symptoms linger despite trying one—or even several—medications.
This doesn't mean you're broken. And it doesn't mean treatment has failed.
It may mean your brain is responding differently. In some cases, this is called treatment-resistant depression (TRD). The good news? There are evidence-based options beyond medication—including TMS therapy—that may help when antidepressants don't.
Let's break down why medications sometimes don't work and what newer treatments can offer.
Antidepressants are often the first-line treatment for depression and certain anxiety disorders. They typically work by adjusting levels of neurotransmitters like serotonin, norepinephrine, and dopamine.
However, research shows:
There are several reasons this happens.
The old explanation that depression is simply a serotonin deficiency is incomplete. Depression involves:
If your depression is driven more by brain circuit dysfunction than by neurotransmitter imbalance, medication alone may not fully address it.
Brain imaging studies show that in depression, certain areas—particularly the left dorsolateral prefrontal cortex (DLPFC)—can be underactive. This region helps regulate mood, decision-making, and emotional control.
When this network is underactive, symptoms may include:
Medication doesn't directly "activate" these circuits. That's where TMS therapy comes in.
Some people metabolize medications too quickly or too slowly. This affects how well drugs work and how many side effects occur.
Other factors include:
It's not a personal failure. It's biology.
Doctors typically define treatment-resistant depression as:
"Resistant" does not mean untreatable. It simply means your brain may need a different approach.
TMS therapy (Transcranial Magnetic Stimulation) is a non-invasive, FDA-cleared treatment for depression that hasn't improved with medication.
Instead of using drugs, TMS therapy uses targeted magnetic pulses to stimulate specific areas of the brain involved in mood regulation.
It does not require anesthesia. It is not electroconvulsive therapy (ECT). It does not cause seizures in standard therapeutic use. You remain awake and alert during treatment.
Unlike antidepressants, which affect the entire body, TMS therapy directly targets the brain circuits involved in depression.
Key differences:
| Antidepressants | TMS Therapy |
|---|---|
| Systemic (whole body) | Targeted brain stimulation |
| Chemical-based | Electrical/magnetic modulation |
| Daily pills | In-office sessions |
| Common side effects | Minimal systemic side effects |
Clinical studies show that many individuals with treatment-resistant depression experience:
Not everyone responds—but many who didn't improve on medication do respond to TMS therapy.
Most patients describe TMS therapy as:
A typical treatment course involves:
After the session, you can:
TMS therapy has been extensively studied and is FDA-cleared for major depressive disorder. It is also being studied for:
Most common side effects:
Serious side effects are rare when proper screening is done.
If you have a history of seizures, metal implants in the head, or certain neurological conditions, your doctor will evaluate whether TMS therapy is appropriate.
You may want to revisit your treatment plan if:
If you're experiencing persistent symptoms while currently on antidepressants, a free online symptom checker can help you identify patterns and prepare important questions before your next doctor's visit.
You may be a good candidate if:
Insurance coverage for TMS therapy has expanded significantly in recent years, particularly for treatment-resistant depression.
It's important to stay realistic.
TMS therapy is not:
The best outcomes often occur when TMS therapy is combined with:
If you are experiencing:
This is urgent. Seek emergency care or contact a crisis service immediately. Do not wait for a routine appointment.
Even if symptoms are not urgent but feel overwhelming, speak to a doctor as soon as possible. Depression is treatable, but it requires proper evaluation.
If your medications aren't working, it does not mean:
It may mean your brain needs a different kind of support.
TMS therapy offers a science-backed, non-invasive option that directly stimulates underactive brain circuits linked to depression. For many people with treatment-resistant depression, it represents a meaningful step forward.
The next step is simple:
Depression can be stubborn. But it is not unbeatable. And you deserve a treatment plan that actually works.
(References)
* Alpert, J. E., & Fava, M. (2018). Neurobiology and Treatment of Treatment-Resistant Depression. *Primary Care Companion for CNS Disorders*, *20*(4).
* Ma, Z., Wu, M., Lu, S., & Wang, X. (2020). Transcranial magnetic stimulation for treatment-resistant depression: An update. *Frontiers in Psychiatry*, *11*, 763.
* Cole, E. J., Stimpson, K. H., Bentzley, B. S., Gulser, M., Wittenberg, L., Tischler, R., ... & Etkin, A. (2020). Accelerated repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression: a systematic review and meta-analysis. *Biological Psychiatry*, *87*(11), 1024–1034.
* Frodl, T., & O'Leary, E. (2017). Neurobiology of treatment-resistant depression: an integrated approach. *Dialogues in Clinical Neuroscience*, *19*(3), 297–306.
* Li, T., Wang, Q., Li, J., Ma, C., Liu, Q., Yang, X., ... & Wei, J. (2021). Predictors and Biomarkers of Response to Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression: A Narrative Review. *Frontiers in Psychiatry*, *12*, 767851.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.